Literature DB >> 18634698

NICE's use of cost effectiveness as an exemplar of a deliberative process.

Anthony J Culyer1.   

Abstract

This paper seeks to test 12 conjectures about the predicted use of deliberative processes by applying them to the technology assessment procedures used by the National Institute for Health and Clinical Excellence (NICE) in England and Wales. A deliberative process is one that elicits and combines evidence of different kinds and from different sources in order to develop guidance - in the present case, guidance for a health care system. A deliberative process entails the integration of three kinds of evidence: scientific context-free evidence about the general clinical potential of a technology, scientific context-sensitive evidence about particular evidence in realistic scenarios, and colloquial evidence to fit context-free scientific evidence into a context and to supply the best evidence short of scientific evidence to fill in any relevant gaps. It is shown that NICE's appraisals procedures and, in particular, its approach to cost effectiveness, entail both the weighing of each of these types of evidence and can be seen as rational responses to the 12 conjectures.

Mesh:

Year:  2006        PMID: 18634698     DOI: 10.1017/S1744133106004026

Source DB:  PubMed          Journal:  Health Econ Policy Law        ISSN: 1744-1331


  7 in total

1.  Evidence, ethics and inclusion: a broader base for NICE.

Authors:  Stephen Wilmot
Journal:  Med Health Care Philos       Date:  2011-05

2.  After 20 Years of Using Economic Evaluation, Should NICE be Considered a Methods Innovator?

Authors:  Mark Sculpher; Stephen Palmer
Journal:  Pharmacoeconomics       Date:  2020-03       Impact factor: 4.981

3.  Use of Evidence-Informed Deliberative Processes - Learning by Doing Comment on "Use of Evidence-informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe".

Authors:  Anthony J Culyer
Journal:  Int J Health Policy Manag       Date:  2020-06-01

4.  Expanding HTA - Correcting a Misattribution, Clarifying the Scope of HTA and CEA Comment on "Ethics in HTA: Examining the 'Need for Expansion'".

Authors:  Anthony J Culyer
Journal:  Int J Health Policy Manag       Date:  2019-12-01

5.  Evidence-Informed Deliberative Processes for HTA Around the Globe: Exploring the Next Frontiers of HTA and Best Practices Comment on "Use of Evidence-informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe".

Authors:  Unni Gopinathan; Trygve Ottersen; Pascale-Renée Cyr; Kalipso Chalkidou
Journal:  Int J Health Policy Manag       Date:  2021-03-14

6.  From little things, big things grow: a local approach to system-wide maternity services reform in the absence of definitive evidence.

Authors:  Anne-Marie Boxall; Kathy Flitcroft
Journal:  Aust New Zealand Health Policy       Date:  2007-09-30

7.  Clearing up the hazy road from bench to bedside: a framework for integrating the fourth hurdle into translational medicine.

Authors:  Wolf H Rogowski; Susanne C Hartz; Jürgen H John
Journal:  BMC Health Serv Res       Date:  2008-09-24       Impact factor: 2.655

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.